Stocks and Investing Stocks and Investing
Mon, July 15, 2024

Drew Ranieri Maintained (TMCI) at Hold with Increased Target to $8 on, Jul 15th, 2024


Published on 2024-10-28 12:27:16 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Hold with Increased Target from $5.5 to $8 on, Jul 15th, 2024.

Drew has made no other calls on TMCI in the last 4 months.



There are 5 other peers that have a rating on TMCI. Out of the 5 peers that are also analyzing TMCI, all agree with Drew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Danielle Antalffy of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $6.5 on, Thursday, May 16th, 2024
  • Richard Newitter of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $7 on, Wednesday, May 8th, 2024
  • Rick Wise of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, May 8th, 2024
  • Robbie Marcus of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $8 on, Wednesday, May 8th, 2024
  • Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, May 8th, 2024

Contributing Sources